抗SARS-CoV / SARS-CoV-2 Nucleocapsid 抗体, 兔单抗, 40143-R001

1, Al-Dalahmah, O; et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta neuropathologica communications, PMID: 32847628
2, Matschke, J; et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. The Lancet. Neurology, PMID: 33031735
3, Jacob, F; et al. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium. Cell stem cell, PMID: 33010822
4, Szabolcs, M; et al. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues. Applied immunohistochemistry & molecular morphology : AIMM, PMID: 33086222
5, Andrews, MG; et al. Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes. bioRxiv : the preprint server for biology, PMID: 33469577
6, Putcharoen, O; et al. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand. PloS one, PMID: 33577615
7, Xu, X; et al. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study. Signal transduction and targeted therapy, PMID: 34006847
8, Bennett, RS; et al. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples. Viruses, PMID: 34065987
9, Renuse, S; et al. A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens. EBioMedicine, PMID: 34229274
10, Avendaño-Ortiz, J; et al. SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19. Journal of immunology (Baltimore, Md. : 1950), PMID: 34183364
11, Kudose, S; et al. Longitudinal Outcomes of COVID-19-Associated Collapsing Glomerulopathy and Other Podocytopathies. Journal of the American Society of Nephrology : JASN, PMID: 34670811
12, Duan, X; et al. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection. Cell reports, PMID: 34731648
13, Bennett, RP; et al. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties. JCI insight, PMID: 34807849
14, Maus, A; et al. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides. Journal of proteome research, PMID: 34779632
15, Golden, JW; et al. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2. mBio, PMID: 35073750
16, Li, Z; et al. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. Cell metabolism, PMID: 35150639
17, Mizutani, M; et al. Pathologic and Neuropathologic Study of a Case of COVID-19. JMA journal, PMID: 35224283
18, Tomris, I; et al. Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns. PLoS pathogens, PMID: 35255100
19, Wang, Z; et al. SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies. Signal transduction and targeted therapy, PMID: 35461307
20, Chong, Z; et al. Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron. bioRxiv : the preprint server for biology, PMID: 35118466
21, Zheng, H; et al. Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques. Cell reports, PMID: 35594870
22, Chong, Z; et al. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron. Cell reports, PMID: 35523172
23, Rosendal, E; et al. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections. mBio, PMID: 35532162
24, Nicholson, MW; et al. Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs. Pharmaceuticals (Basel, Switzerland), PMID: 35745684
25, Wang, L; et al. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity. The Journal of cell biology, PMID: 35674692
26, Vanderboom, PM; et al. Machine Learning-Based Fragment Selection Improves the Performance of Qualitative PRM Assays. Journal of proteome research, PMID: 35849720
27, Xue, Y; et al. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19. Viruses, PMID: 35891384
28, Lee, S; et al. Immunological and Pathological Peculiarity of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant. Microbiology spectrum, PMID: 36005818
29, Coler, B; et al. Diminished Antiviral Innate Immune Gene Expression in the Placenta Following a Maternal SARS-CoV-2 Infection. American journal of obstetrics and gynecology, PMID: 36126729
30, Khan, M; et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients. Neuron, PMID: 36446381
31, Lindqvist, R; et al. A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses. Viruses, PMID: 36298757
32, Chen, M; et al. Infection of SARS-CoV-2 causes severe pathological changes in mouse testis. Journal of genetics and genomics = Yi chuan xue bao, PMID: 36494057
33, Que, H; et al. Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy, PMID: 36566328
34, Wang, Y; et al. Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5. Cell discovery, PMID: 36609558
35, Higashi-Kuwata, N; et al. Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2. Nature communications, PMID: 36841831
36, Emmi, A; et al. Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei. NPJ Parkinson's disease, PMID: 36781876
37, Massimo, M; et al. Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection. Brain : a journal of neurology, PMID: 36642091
38, Qiu, S; et al. Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine. Signal transduction and targeted therapy, PMID: 36922500
39, Nchioua, R; et al. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1. Life science alliance, PMID: 36977594
40, Dickey, TH; et al. Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines. Cell reports, PMID: 36943870
41, Alhammad, YM; et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice. bioRxiv : the preprint server for biology, PMID: 37066301
42, Byström, JW; et al. At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, PMID: 36995373
43, Yue, M; et al. Coronaviral ORF6 protein mediates inter-organelle contacts and modulates host cell lipid flux for virus production. The EMBO journal, PMID: 37218505
44, Van Slambrouck, J; et al. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients. EBioMedicine, PMID: 37224768
45, Min, YQ; et al. A new cellular interactome of SARS-CoV-2 nucleocapsid protein and its biological implications. Molecular & cellular proteomics : MCP, PMID: 37211047
46, Burnap, SA; et al. Cross-linking Mass Spectrometry Uncovers Interactions Between High-density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein. Molecular & cellular proteomics : MCP, PMID: 37343697
47, Addetia, A; et al. Neutralization, effector function and immune imprinting of Omicron variants. Nature, PMID: 37648855
48, Alhammad, YM; et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice. Proceedings of the National Academy of Sciences of the United States of America, PMID: 37607224
49, Hirata, Y; et al. Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19. Journal of medical virology, PMID: 37537838 50, Ford, ES; et al. Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19. Nature immunology, PMID: 38057617 51, Sasaki, M; et al. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model. EBioMedicine, PMID: 38159532
52, Garvanska, DH; et al. The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions. EMBO reports, PMID: 38177924
53, Uraki, R; et al. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. NPJ vaccines, PMID: 38167505
54, Yang, L; et al. SARS-CoV-2 infection causes dopaminergic neuron senescence. Cell stem cell, PMID: 38237586
55, Nagasawa, S; et al. Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses. PloS one, PMID: 38536820
56, Wang, W; et al. Digital Surface-Enhanced Raman Spectroscopy-Lateral Flow Test Dipstick: Ultrasensitive, Rapid Virus Quantification in Environmental Dust. Environmental science & technology, PMID: 38452107
57, Du, H; et al. Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis. Journal of genetics and genomics = Yi chuan xue bao, PMID: 38447818
58, Jeong, GU; et al. Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis. Experimental & molecular medicine, PMID: 38816566
59, Liu, B; et al. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike. Cell reports, PMID: 38805396 60, Komiya, Y; et al. Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection. Biochimica et biophysica acta. Molecular basis of disease, PMID: 39154794 61, Yabu, H; et al. Janus-Type Immunofluorescent Probes and a Quantitative Immunoassay System. Langmuir : the ACS journal of surfaces and colloids, PMID: 39145991
62, Rosen, LE; et al. A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification. Cell, PMID: 39383863
63, Chaopreecha, J; et al. Andrographolide attenuates SARS-CoV-2 infection via an up-regulation of glutamate-cysteine ligase catalytic subunit (GCLC). Phytomedicine : international journal of phytotherapy and phytopharmacology, PMID: 39631298
64, Lee, JH; et al. Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults. mSphere, PMID: 39723823
65, Nakamura, S; et al. Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes. Proceedings of the National Academy of Sciences of the United States of America, PMID: 39854234
66, Xing, L; et al. Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target. Cell, PMID: 39889696
67, Han, S; et al. Host specific sphingomyelin is critical for replication of diverse RNA viruses. Cell chemical biology, PMID: 39566509
68, Liu, A; et al. Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy. Clinical science (London, England : 1979), PMID: 39666439
69, Shull, T; et al. Elevated neuroinflammation, autoimmunity, and altered IgG glycosylation profile in the cerebral spinal fluid of severe COVID-19 patients. Brain, behavior, and immunity, PMID: 40157461 70, Oba, S; et al. Iguratimod, a promising therapeutic agent for COVID-19 that attenuates excessive inflammation in mouse models. European journal of pharmacology, PMID: 40147575 71, Kubinski, HC; et al. Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation. PLoS biology, PMID: 40299982
72, Vacharathit, V; et al. Persistent IP-10/CXCL10 dysregulation following mild omicron breakthrough infection: Immune network signatures across COVID-19 waves and implications for mRNA vaccine outcomes. Clinical immunology (Orlando, Fla.), PMID: 40306350
73, Sadler, CJ; et al. Signal Enhancement in Immunoassays via Coupling to Catalytic Nanoparticles. ACS sensors, PMID: 40390533
74, Wei, X; et al. Immune imprinting blunts omicron pathogenicity fluctuations and highlights the essential role of cellular immunity in SARS-CoV-2 infection. Cell reports, PMID: 40471788
75, Lam, JY; et al. The Recurring Loss of ORF8 Secretion in Dominant SARS-CoV-2 Variants. International journal of molecular sciences, PMID: 40565240
76, Gu, ZQ; et al. TRPML2 channel modulation by PI(
3,5)P₂ and small-molecule agonists controls endosomal vesicle dynamics. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, PMID: 40664038
77, Parthasarathy, S; et al. PARP14 is an interferon-induced host factor that promotes IFN production and affects the replication of multiple viruses. mBio, PMID: 40937852
78, Chen, L; et al. Impact of obstructive sleep apnea severity and treatment on COVID-19 vaccine-induced immune responses. Journal of thoracic disease, PMID: 40950906